Emergent Health 

$0.000100
7
+$0.00+0% Friday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0003
52W Low
0.0001
Volume
100,000
Avg. Volume
26,735
Mkt Cap
42,695.1
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2010
Q1 2011
Q2 2011
Q3 2011
Q2 2013
Q3 2013
Q2 2014
-0
0
0
0.01
Expected EPS
0
Actual EPS
-0.0019

Financials

-99.57%Profit Margin
Unprofitable
2014
2019
2020
2021
2022
2023
1.64MRevenue
-1.63MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes with Emergent Health in the development and marketing of medications and vaccines for a wide range of medical conditions.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceutical sector, offering products that directly compete with Emergent Health's offerings in healthcare solutions.
Merck
MRK
Mkt Cap366B
Merck is a leading pharmaceutical company that develops drugs and vaccines, competing with Emergent Health in various therapeutic areas.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that competes with Emergent Health in the development of treatments for infectious diseases, among other areas.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie is a research-based biopharmaceutical company that competes with Emergent Health in developing advanced therapies for complex health conditions.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotechnology company focused on human therapeutics, competing with Emergent Health in the biotech and healthcare sector.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Emergent Health in the discovery, development, and delivery of medicines.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes with Emergent Health in providing healthcare solutions across a broad range of therapies.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global biopharmaceutical company focused on human health, competing with Emergent Health in the development of pharmaceuticals and vaccines.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company, competing with Emergent Health in the development and commercialization of prescription medicines.

About

Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being. Another key offering is Neuvitale, which not only assists in nourishing stem cells but also serves as a methyl donor to safeguard DNA integrity. For appetite regulation, they provide Hungarest, a dietary aid designed to manage hunger signals originating from both the brain and stomach. Additionally, EmergentO2 is available as a water oxygenator, aiming to elevate oxygen levels within the bloodstream. The firm also develops and markets several solutions for diminishing facial wrinkles. These products are distributed through a wide network of health food stores, pharmacies, and diverse other retail channels, reaching consumers throughout the United States and globally. Based in King of Prussia, Pennsylvania, Emergent Health Corp. transitioned to private ownership as of August 26, 2014.
Show more...
CEO
James W. Zimbler
Employees
6
Country
United States
ISIN
US29100Q3083

Listings

0 Comments

Share your thoughts

FAQ

What is Emergent Health stock price today?
The current price of EMGE is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Emergent Health stock price performance more closely on the chart.
What is Emergent Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Emergent Health stocks are traded under the ticker EMGE.
Is Emergent Health stock price growing?
EMGE stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Emergent Health has showed a +0% increase.
What is Emergent Health market cap?
Today Emergent Health has the market capitalization of 42,695.1
What were Emergent Health earnings last quarter?
EMGE earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Emergent Health revenue for the last year?
Emergent Health revenue for the last year amounts to 1.64M USD.
What is Emergent Health net income for the last year?
EMGE net income for the last year is -1.63M USD.
How many employees does Emergent Health have?
As of September 05, 2026, the company has 6 employees.
In which sector is Emergent Health located?
Emergent Health operates in the Health & Wellness sector.
When did Emergent Health complete a stock split?
The last stock split for Emergent Health was on July 24, 2008 with a ratio of 1:50.
Where is Emergent Health headquartered?
Emergent Health is headquartered in King of Prussia, United States.